Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Gaylor

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 24, 2004
Mad cow hysteriaDavid W Gaylor
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 25, 2005
Risk/benefit assessments of human diseases: optimum dose for interventionDavid W Gaylor
Regulatory Toxicology and Pharmacology : RTP|February 9, 2005
Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?David W Gaylor
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 18, 2003
Commentary on the conference on decision-making under conditions of uncertainty for rare diseasesDavid W Gaylor
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 22, 2005
Role of the standard deviation in the estimation of benchmark doses with continuous dataDavid W Gaylor, William Slikker
Regulatory Toxicology and Pharmacology : RTP|July 22, 2004
An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD)David W Gaylor, Lesa L Aylward
Regulatory Toxicology and Pharmacology : RTP|June 8, 2002
A procedure for developing risk-based reference dosesDavid W Gaylor, Ralph L Kodell
Chemical Research in Toxicology|April 24, 2008
Dose-response relationships for cancer incidence reflect susceptibility distributionsWerner K Lutz, David W Gaylor
Mutation Research|July 13, 2002
Statistical calculation of detection limits for DNA adducts using the 32P-postlabeling assay with a standard addition procedureWerner K Lutz, Ursula Lutz, David W Gaylor
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 23, 2003
Thresholds of carcinogenicity in the ED01 studyMelvin E Andersen, Rory B Conolly, David W Gaylor
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Risk Analysis : an Official Publication of the Society for Risk Analysis|June 24, 2004
Mad cow hysteriaDavid W Gaylor
Risk Analysis : an Official Publication of the Society for Risk Analysis|March 25, 2005
Risk/benefit assessments of human diseases: optimum dose for interventionDavid W Gaylor
Regulatory Toxicology and Pharmacology : RTP|February 9, 2005
Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?David W Gaylor
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 18, 2003
Commentary on the conference on decision-making under conditions of uncertainty for rare diseasesDavid W Gaylor
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 22, 2005
Role of the standard deviation in the estimation of benchmark doses with continuous dataDavid W Gaylor, William Slikker
Regulatory Toxicology and Pharmacology : RTP|July 22, 2004
An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD)David W Gaylor, Lesa L Aylward
Regulatory Toxicology and Pharmacology : RTP|June 8, 2002
A procedure for developing risk-based reference dosesDavid W Gaylor, Ralph L Kodell
Chemical Research in Toxicology|April 24, 2008
Dose-response relationships for cancer incidence reflect susceptibility distributionsWerner K Lutz, David W Gaylor
Mutation Research|July 13, 2002
Statistical calculation of detection limits for DNA adducts using the 32P-postlabeling assay with a standard addition procedureWerner K Lutz, Ursula Lutz, David W Gaylor
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 23, 2003
Thresholds of carcinogenicity in the ED01 studyMelvin E Andersen, Rory B Conolly, David W Gaylor
Pageof 3